v3.26.1
ACQUISITIONS AND INVESTMENTS - Additional Information (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 19, 2026
EUR (€)
Mar. 12, 2026
USD ($)
Mar. 12, 2026
EUR (€)
Feb. 26, 2026
USD ($)
Feb. 09, 2026
USD ($)
Feb. 06, 2026
USD ($)
shares
Jan. 15, 2026
USD ($)
$ / shares
Jan. 13, 2026
USD ($)
$ / shares
shares
Nov. 30, 2025
USD ($)
$ / shares
shares
Oct. 31, 2025
USD ($)
Mar. 14, 2025
USD ($)
Mar. 31, 2026
USD ($)
shares
Mar. 31, 2026
USD ($)
shares
Mar. 31, 2026
USD ($)
shares
Mar. 31, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
shares
Mar. 31, 2025
USD ($)
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Jan. 31, 2026
USD ($)
Jan. 13, 2026
EUR (€)
Nov. 30, 2025
EUR (€)
Mar. 14, 2025
£ / shares
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage required for significant influence                       20.00% 20.00% 20.00% 20.00%                
Research and Development Expense                           $ 67,500     $ 184,563 $ 174,559 $ 1,821,816        
Common stock, shares issued | shares                       154,588,426 154,588,426 154,588,426 154,588,426 92,816,561   92,816,561 4,062,974        
Nominal value                           $ 749,905                  
Change in fair value of convertible notes receivable                           1,073,803     0 $ (2,679,772) $ 0        
Principal amount outstanding                       $ 39,776,987 $ 39,776,987 39,776,987 $ 39,776,987 $ 25,458,016   25,458,016          
Subscription for orbit shares                               11,778,600   11,778,600          
Interest expense                           71,212     193,480 472,381 3,346,896        
Revenue                           407,644     0 0 152,127        
Net loss                           (459,898)     (16,611,425) (79,071,276) (34,515,754)        
Issuance of Common Stock                           2,150,836         200,000        
Change in fair value of derivative liability                           (4,909,820)     (37,900) (37,900) $ (141,100)        
Reclassification of derivative liability in connection with amendment to Orbit Preferred Obligation                           2,505,010                  
Gain on extinguishment of Orbit Preferred Obligation in excess of derivative liability fair value, recognized as a capital contribution (related party)                           784,807                  
Advance on Tekne Convertible Receivable                                   $ 1,179,686          
Issuance of Tekne Subordinated Convertible Note                           928,000                  
Gain on initial recognition of Tekne Investment                           84,000     0            
Orbit Amendment [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Issuance of Common Stock         $ 10,020,040                                    
Change in fair value of derivative liability                       4,909,820                      
Reclassification of derivative liability in connection with amendment to Orbit Preferred Obligation                       2,505,010                      
Gain on extinguishment of Orbit Preferred Obligation in excess of derivative liability fair value, recognized as a capital contribution (related party)                       784,807                      
Orbit preferred obligation in excess of derivative liability carrying value         8,199,636                                    
Orbit preferred obligation in excess of derivative liability fair value         $ 7,414,830                                    
Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Aggregate purchase price             $ 2,310,558                                
Business acquisition, cash paid             $ 750,000                                
Revenue                           340,365                  
Net loss                             7,466                
Business acquisition date of acquisition agreement             Jan. 15, 2026                                
Payments to acquire ownership interest in cash             $ 750,000                                
Promissory notes, principal amount             1,250,000                                
Debt instrument face amount             $ 1,000,000                                
Potential earn out payment period             5 years                                
Funding written notice period             30 days                                
Percentage of earn-out entitled             30.00%                                
Identifiable intangible assets             $ 535,400                                
Fair value of contingent consideration             138,558                                
Lyocon Acquisition [Member] | Debt [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Debt instrument face amount             500,000                                
Lyocon Acquisition [Member] | Short-Term Debt [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Debt instrument face amount             250,000                                
Lyocon Acquisition [Member] | Long-Term Debt [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Debt instrument face amount             250,000                                
Lyocon Acquisition [Member] | Location, Statement of Income, Balance [Axis]: us-gaap:GeneralAndAdministrativeExpense                                              
Schedule of Equity Method Investments [Line Items]                                              
Acquisition-related costs                           308,169                  
Lyocon Acquisition [Member] | Trade names / trademarks [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Identifiable intangible assets             $ 62,770                                
Acquired intangible assets useful lives             5 years                                
Lyocon Acquisition [Member] | Cash Earnout [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Contingent consideration liability             $ 1,000,000                                
Lyocon Acquisition [Member] | Cash Earnout [Member] | Minimum                                              
Schedule of Equity Method Investments [Line Items]                                              
Undiscounted amount to pay in earn-out             0                                
Lyocon Acquisition [Member] | Cash Earnout [Member] | Maximum                                              
Schedule of Equity Method Investments [Line Items]                                              
Undiscounted amount to pay in earn-out             1,000,000                                
Tekne Transaction [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Escrow deposit amount                       4,200,000 4,200,000 4,200,000 4,200,000                
Issuance of Tekne Subordinated Convertible Note               $ 928,000                              
Gain on initial recognition of Tekne Investment               $ 84,000                              
H&K Investment Agreement [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Aggregate purchase price           $ 15,000,000                                  
Common stock, shares issued | shares           295,000                                  
Percentage of outstanding common shares           0.80%                                  
Transaction expenses                       $ 22,134 $ 22,134 $ 22,134 $ 22,134                
January 2026 Tekne Agreements [Member] | Tekne Transaction [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Business acquisition date of acquisition agreement                 Nov. 30, 2025                            
Equity interest               2.90% 2.90%                       2.90% 2.90%  
Provision for convertible receivable | €                                         € 13,000,000 € 13,000,000  
Assets guaranteed               $ 4,200,000                              
Advance on Tekne Convertible Receivable                               $ 1,179,686              
January 2026 Tekne Agreements [Member] | Tekne Transaction [Member] | Letter of Credit [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Cash collateral                                       $ 875,000      
Tekne Convertible Receivable [Member] | Tekne Transaction [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Provision for convertible receivable | €                                           € 13,000,000  
Debt instrument, maturity date                 Jan. 13, 2027                            
Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member] | Minimum                                              
Schedule of Equity Method Investments [Line Items]                                              
Increase of convertible receivable amount | € € 13,000,000                                            
Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member] | Maximum                                              
Schedule of Equity Method Investments [Line Items]                                              
Increase of convertible receivable amount | € 16,692,000                                            
GP Authorization [Member] | March 2026 Tekne Letter [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Capital increase amount | € € 13,000,000                                            
Interest Acquisition [Member] | Tekne Transaction [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity interest                 0.00%                         0.00%  
Subordinated convertible note principal amount               $ 1,740,000 $ 1,740,000                            
Debt instrument, maturity date                 Jan. 31, 2027                            
Subordinated convertible note converted shares | shares               1,394,790 1,394,790                            
Conversion price per share | $ / shares               $ 1.25 $ 1.25                            
Lyocon Purchase Agreement [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Business acquisition, cash paid             $ 2,000,000                                
Equity Awards Equal to 0.07% of Market Cap [Member] | Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Share price | $ / shares             $ 3.49                                
Number of consecutive trading days             20 days                                
Percentage of entitlement of equity awards to market cap             0.07%                                
Equity Awards Equal to 0.10% of Market Cap [Member] | Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Share price | $ / shares             $ 4.99                                
Number of consecutive trading days             20 days                                
Percentage of entitlement of equity awards to market cap             0.10%                                
Equity Awards Equal to 0.15% of Market Cap [Member] | Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Share price | $ / shares             $ 9.98                                
Number of consecutive trading days             20 days                                
Percentage of entitlement of equity awards to market cap             0.15%                                
Developed Technology Rights [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Average useful life                       5 years 4 months 24 days 5 years 4 months 24 days 5 years 4 months 24 days 5 years 4 months 24 days                
Developed Technology Rights [Member] | Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Identifiable intangible assets             $ 348,720                                
Acquired intangible assets useful lives             8 years                                
Customer Relationships [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Average useful life                       7 years 3 months 18 days 7 years 3 months 18 days 7 years 3 months 18 days 7 years 3 months 18 days 7 years   7 years          
Customer Relationships [Member] | Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Identifiable intangible assets             $ 267,352                                
Acquired intangible assets useful lives             8 years                                
Orbit [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment                               $ 949,806   $ 949,806          
Equity method investment, ownership percentage             22.00%     10.70%   10.70% 10.70% 10.70% 10.70%         22.00%      
Aggregate purchase price             $ 16,592,107                                
Business acquisition, cash paid             2,000,000                 1,500,000              
Proportionate share of net assets | shares                                   1,112,750          
Business acquisition, consideration advance payment                                   $ 3,750,000          
Settlement date                   Dec. 31, 2026       Dec. 31, 2026                  
Subscription for orbit shares                               11,778,600   11,778,600          
Fair value of orbit preferred obligation                                   8,028,600          
Deposit on acquisition                               $ 733,272   733,272          
Interest expense                           $ 67,737     $ 0 $ 103,299          
Equity interest previously held fair value                       $ 890,398 $ 890,398 890,398 $ 890,398                
Equity remeasurement loss                           59,408                  
Transaction expenses                       $ 212,360 $ 212,360 212,360 $ 212,360                
Revenue                           67,279                  
Net loss                           $ 88,507                  
Identifiable intangible assets             $ (895,586)                                
Purchase of ownership interest             22.00%     10.70%   10.70% 10.70% 10.70% 10.70%         22.00%      
Orbit [Member] | Developed Technology Rights [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Amortized years                               5 years   5 years          
Identifiable intangible assets             $ 2,092,320                                
Orbit [Member] | Customer Relationships [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Identifiable intangible assets             $ 139,488                                
Orbit [Member] | Nuburu Defense [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment                   $ 5,000,000           $ 1,500,000   $ 1,500,000          
Equity method investment, final tranche closing date                   Oct. 07, 2028                          
Equity method investment, ownership percentage                               10.70%   10.70%          
Equity method investment, ownership percentage required for amendment of bylaws                   20.00%                          
Business acquisition, final tranche closing date                   Dec. 31, 2026                          
Aggregate purchase price                   $ 12,500,000                          
Business acquisition, cash paid                   3,750,000                          
Business combination, non-cash consideration                   $ 8,750,000                          
Exclusive rights period upon letter of intent                   36 months                          
Purchase of ownership interest                               10.70%   10.70%          
Orbit [Member] | Nuburu Defense [Member] | Alessandro Zamboni [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Business acquisition, consideration advance payment                               $ 3,750,000   $ 3,750,000          
Business acquisition, consideration offsetting credit payment                               1,350,000   1,350,000          
Business combination, consideration, remaining advance payment                               $ 2,400,000   2,400,000          
NewCo [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Percentage of capital owned       60.00%                                      
SYME Strategic Investment [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Inventory monetization advanced                                   $ 5,668,545          
Nominal value                     $ 5,150,000                        
Conversion price per share | £ / shares                                             £ 0.000039
SYME 3 [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Variable Interest Entity Ownership Percentage                           100.00%                  
Variable interest entity ownership, expected losses and residual returns percentage                           100.00%                  
SYME 3 [Member] | Bond Subscription Agreement [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Issuance in variable rate bonds | €     € 30,000,000                                        
Nominal value | €     € 5,250,000                                        
Maturity date   2029-03 2029-03                                        
Subscription price | €     € 4,824,294                                        
Subscription price paid   $ 5,668,545 € 4,824,294                                        
Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]   us-gaap:EurodollarMember us-gaap:EurodollarMember                                        
Basis spread margin on variable rate   7.50% 7.50%                                        
Cap rate 12.00%                                            
Notice for redemption on bond payment date   120 days 120 days                                        
Change in fair value of convertible notes receivable   $ 5,718,059                       $ 5,685,021                  
Principal amount outstanding                       $ 6,036,450 $ 6,036,450 6,036,450 $ 6,036,450                
Discount on nominal amount | €     € 425,706                                        
Lyocon [Member] | Lyocon Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage             50.00%                                
Purchase of ownership interest             50.00%                                
Tekne [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage                                       2.90%      
Purchase of ownership interest                                       2.90%      
Tekne [Member] | March 2026 Tekne Letter [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage 70.00%                                            
Payments to acquire ownership interest in cash | € € 6,000,000                                            
Purchase of ownership interest 70.00%                                            
Tekne [Member] | Tekne Convertible Receivable [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage                 27.90%                         27.90%  
Purchase of ownership interest                 27.90%                         27.90%  
Tekne [Member] | Tekne Convertible Receivable [Member] | March 2026 Tekne Letter [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Convertible receivable interest rate 32.10%                                            
Tekne [Member] | GP Authorization [Member] | March 2026 Tekne Letter [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Percentage of capital increase 25.00%                                            
Percentage of subject to obtaining interest 60.00%                                            
Percentage of additional subject to obtaining interest 10.00%                                            
Tekne [Member] | Interest Acquisition [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage                 2.90%                         2.90%  
Purchase of ownership interest                 2.90%                         2.90%  
Tekne [Member] | Interest Acquisition [Member] | Tekne Purchase Agreement [member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Equity method investment, ownership percentage               2.90% 2.90%                       2.90% 2.90%  
Purchase of ownership interest               2.90% 2.90%                       2.90% 2.90%  
Maddox Joint Venture [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Development funds       $ 4,000,000                                      
Percentage of development funds       10.00%                                      
Percentage of capital owned       40.00%                                      
Joint venture, exclusive rights period       5 years                                      
Joint venture term       1 year                                      
Notice of non-renewal       90 days                                      
Research and Development Expense                           $ 67,500                  
Joint venture cash payments                         $ 289,000                    
Mr. D'Arrezzo [Member] | GP Authorization [Member] | March 2026 Tekne Letter [Member]                                              
Schedule of Equity Method Investments [Line Items]                                              
Percentage of subject to obtaining interest 2.90%